经导管主动脉瓣置换术后持续性肺动脉高压的结局
该研究纳入2011年7月至2016年1月连续接受TAVR的患者407例,67%存在基线肺动脉高压,其中25%在术后1个月持续存在中度及以上肺动脉高压。持续中度及以上肺动脉高压与全因死亡率独立相关(HR=1.82,95%CI 1.06-3.12,p=0.03)。
要点
- TAVR患者基线肺动脉高压常见(67%),术后1个月持续中度及以上者占25%。
- 持续中度及以上肺动脉高压与2年全因死亡率升高独立相关(HR=1.82)。
- 三尖瓣反流、二尖瓣反流、房颤/房扑等与持续肺动脉高压相关。
核心结论
- TAVR术后1个月持续存在中度及以上肺动脉高压较常见,且与较高的全因死亡率独立相关。
研究设计与样本
- 连续纳入2011年7月至2016年1月接受TAVR的患者407例,基线肺动脉高压定义为右心导管平均肺动脉压≥25 mm Hg。
- 持续中度及以上肺动脉高压定义为术后1个月经胸多普勒超声估测肺动脉收缩压>45 mm Hg。
- 采用Cox模型校正混杂因素分析持续肺动脉高压对后续死亡率的影响。
主要发现
- 407例TAVR患者中273例(67%)存在基线肺动脉高压,其中102例(25%)术后1个月持续存在中度及以上肺动脉高压。
- 无基线肺动脉高压、肺动脉高压改善(随访肺动脉收缩压≤45 mm Hg)和持续中度及以上肺动脉高压患者2年死亡率分别为15.4%、16.6%和31.3%(p=0.049)。
- 校正STS预测死亡风险和基线右心室功能(三尖瓣环收缩期位移)后,持续中度及以上肺动脉高压仍与全因死亡率相关(HR=1.82,95%CI 1.06-3.12,p=0.03)。
- 与持续中度及以上肺动脉高压可能性增加相关的基线特征包括:中度及以上三尖瓣反流、中度及以上二尖瓣反流、心房颤动/扑动、E/A比值和左心房容积指数。
关键数值与推荐
- 基线肺动脉高压:右心导管平均肺动脉压≥25 mm Hg。
- 持续中度及以上肺动脉高压:术后1个月经胸多普勒超声肺动脉收缩压>45 mm Hg。
- 持续中度及以上肺动脉高压与全因死亡率相关:HR=1.82,95%CI 1.06-3.12,p=0.03。
临床怎么用
- TAVR术前应评估肺动脉高压及瓣膜反流、房颤等持续肺动脉高压相关因素。
- TAVR术后1个月应通过超声评估肺动脉收缩压,识别持续肺动脉高压患者。
- 对术后持续中度及以上肺动脉高压患者,可考虑加强随访和风险分层管理。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the prevalence and factors associated with persistent pulmonary hypertension (PH) following transcatheter aortic valve replacement (TAVR) and its relationship with long-term mortality. METHODS: Consecutive patients who underwent TAVR from July 2011 through January 2016 were studied. The prevalence of baseline PH (mean pulmonary artery pressure ≥25 mm Hg on right heart catheterisation) and the prevalence and the predictors of persistent≥moderate PH (pulmonary artery systolic pressure (PASP)>45 mm Hg on 1 month post-TAVR transthoracic Doppler echocardiography) were collected. Cox models quantified the effect of persistent PH on subsequent mortality while adjusting for confounders. RESULTS: Of the 407 TAVR patients, 273 (67%) had PH at baseline. Of these, 102 (25%) had persistent≥moderate PH. Mortality at 2 years in patients with no baseline PH versus those with PH improvement (follow-up PASP≤45 mm Hg) versus those with persistent≥moderate PH was 15.4%, 16.6% and 31.3%, respectively (p=0.049). After adjusting for Society of Thoracic Surgeons Predicted Risk of Mortality and baseline right ventricular function (using tricuspid annular plane systolic excursion), persistent≥moderate PH remained associated with all-cause mortality (HR=1.82, 95% CI 1.06 to 3.12, p=0.03). Baseline characteristics associated with increased likelihood of persistent≥moderate PH were ≥moderate tricuspid regurgitation, ≥moderate mitral regurgitation, atrial fibrillation/flutter, early (E) to late (A) ventricular filling velocities (E/A ratio) and left atrial volume index. CONCLUSIONS: Persistency of even moderate or greater PH at 1 month post-TAVR is common and associated with higher all-cause mortality.
引用
- Masri A, Abdelkarim I, Sharbaugh MS, et al. Outcomes of persistent pulmonary hypertension following transcatheter aortic valve replacement. Heart. 2017. PMID: 28970276. doi:10.1136/heartjnl-2017-311978
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。